On January 9, 2024, Adhera Therapeutics, Inc. received notice from Trond K. Waerness that he was resigning from Board of Directors effective January 12, 2024. Mr. Waerness? decision to resign as director was not the result of any disagreement with the company on any matter relating to the Company?s operations, policies, or practices.

Further, on January 12, 2024, the company received notice from Zahed Subhan that he was resigning as the company?s Chief Executive Officer and as a member of the Company?s Board of Directors. Mr. Subhan?s decision to resign as Chief Executive Officer and member of the Company?s Board of Directors was not the result of any disagreement with the Company on any matter relating to the Company?s operations, policies, or practices.